A study of the alpha-subunits of brain GTP-binding proteins from patients suffering schizophrenic, or Alzheimer's disease
A study of the alpha-subunits of brain GTP-binding proteins from patients suffering schizophrenic, or Alzheimer's disease
批准号:
03454286
负责人:
OKADA Fumihiko
金额:
$4.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992
中文摘要
采用高灵敏的酶免疫分析法,研究了gtp结合蛋白α亚基、氧化石墨烯(Go α)和Gi2 (Gi2alpha)在对照组和精神分裂症死后大脑6个区域的浓度。与对照组相比,精神分裂症患者右半球海马体中的α显著降低;SAS分析显示了显著的诊断x侧相互作用。在大脑的其他区域,根据诊断、侧面、年龄、性别和死后延迟进行分组分析显示,对照组和精神分裂症患者之间的Goalpha没有显著差异。Gi2alpha的浓度在各区域无显著差异。这些发现与adp核糖基化的结果形成对比,后者显示对侧(左)半球海马和壳核中百日咳毒素adp核糖基化的量减少。这种差异可能是由于精神分裂症患者左右侧海马体中存在不同的Go或Gi1构象。
英文摘要
Concentrations of the alpha subunits of GTP-binding protein, Go (Goalpha) and of Gi2 (Gi2alpha) in 6 areas of control and schizophrenic post-mortem brains were investigated using the highly sensitive enzyme immunoassay method. There was a significant decrease in Goalpha in the hippocampus of the right hemisphere in schizophrenic patients compared to controls; SAS analysis demonstrated a significant diagnosis x side interaction. In other areas of the brain, analysis by grouping under diagnosis, side, age, gender and postmortem delay showed no significant deviations in Goalpha between controls and schizophrenics. The concentrations of Gi2alpha did not differ significantly in any area. These findings contrasted with the results yielded by ADP-ribosylation, which showed decreased pertussis toxin ADP-ribosylated amounts in the hippocampus and putamen of the contralateral (left) hemisphere. The discrepancy might be explained by the existence of differing conformations of Go or Gi1 in the hippocampi of the right and left sides in schizophrenics.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Fumihiko Okada: "Is the tendency to weep one of the most useful indicators for depressed mood?" J.Clin.Psychiatry. 52. 351-352 (1991)
冈田文彦:“哭泣的倾向是抑郁情绪最有用的指标之一吗?”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fumihiko Okada: "Reverse placebo effects:anticipation/anxiety at the possibility of receiving placebos." Ann.Pharmacotherapy. 26. 128 (1992)
Fumihiko Okada:“反向安慰剂效应:对接受安慰剂的可能性的预期/焦虑。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fumihiko Okada: "Reverse placebo effects:anticipation/anxiety at the possibility of receiving placebos." Ann.Pharmacotherapy. 26. 128- (1992)
Fumihiko Okada:“反向安慰剂效应:对接受安慰剂的可能性的预期/焦虑。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fumihiko Okada;Timothy J.Crow;Gareth W.Roberts: "G proteins(Gi,Go)in the medial temporal lobe in schizophrenia:preliminary report of a neurochemical correlate of structural change." J.Neural Transm.84. 147-153 (1991)
Fumihiko Okada;Timothy J.Crow;Gareth W.Roberts:“精神分裂症内侧颞叶中的 G 蛋白(Gi,Go):与结构变化相关的神经化学的初步报告。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fumihiko Okada;Toshimitu Aida;Hiroshi Abe: "Schizophrenic symptoms induced by a tumor of the left basal ganglia with ipsilateral cerebral hemiatrophy." Ann.Clin.Psychiatry. (1992)
Fumihiko Okada;Toshimitu Aida;Hiroshi Abe:“左侧基底神经节肿瘤伴同侧大脑偏侧萎缩引起的精神分裂症症状。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 12 条
海外基金